This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Why price level matters is that it frames where supply and demand meet, shaping momentum and risk. Use this context to make smarter choices.
28,103 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
Robinhood stock soared from its spring lows, delivering a eye-catching rally. But a deeper look at revenue mix, regul...
Investors are looking at SMH with fresh eyes as AI infrastructure expands. This article explains why a bold predictio...
A major move in the short-term Treasury market reveals how a focused investment strategy can lift cash management ret...
As electricity demand climbs, NuScale Power presents a rare risk reward. This piece lays out one compelling buy reaso...
A big move by an asset manager can ripple through a stock’s price and its story. This article explains what asset man...
When a top toy maker’s stock plunges and an active fund exits, investors sit up and take notice. This article unpacks...
Geopolitics can move markets fast. When tensions rise, like with Iran, volatility spikes and portfolios feel the stra...
Two months can change a market outlook dramatically. This piece breaks down why the idea of an opinion: stock market ...
MercadoLibre and Walmart have faced headwinds this year, despite solid earnings. This guide breaks down which stock o...
As markets brace for a mid-month catalyst, March 16 could be a pivotal moment. This guide breaks down the drivers, sc...